COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
Clinical trial NCT05301881 · RECRUITING
Trial details
- NCT number
- NCT05301881
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2035-04-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.